Cookson defends TUE system as being more rigorous since Wiggins' applications

UCI president Brian Cookson has said the process by which therapeutic use exemptions (TUEs) are approved is more rigorous now than when Bradley Wiggins was allowed injections of the powerful corticosteroid triamcinolone acetonide in 2011, 2012 and 2013. Cookson declined to discuss the specifics of the case in a press conference at the World Championships in Doha on Saturday.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Barry Ryan
Head of Features

Barry Ryan is Head of Features at Cyclingnews. He has covered professional cycling since 2010, reporting from the Tour de France, Giro d’Italia and events from Argentina to Japan. His writing has appeared in The Independent, Procycling and Cycling Plus. He is the author of The Ascent: Sean Kelly, Stephen Roche and the Rise of Irish Cycling’s Golden Generation, published by Gill Books.